These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6760450)

  • 1. [Clinical experience with theophylline in slow-release form (Theo-dur)].
    Jørstad SO; Omenaas E
    Tidsskr Nor Laegeforen; 1982 May; 102(13):747-9. PubMed ID: 6760450
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T; Józefczak E; Raczka A
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1986 Sep; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial of a pediatric oral sustained-release theophylline preparation].
    Zach M; Grubbauer HM; Kump H
    Prax Klin Pneumol; 1984 May; 38(5):182-7. PubMed ID: 6379635
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the plasma profiles of two slow release theophylline preparations in asthmatic patients and healthy volunteers.
    Langaker KE; Bredesen JE; Holland A
    Br J Clin Pract Suppl; 1984; 35():50-2. PubMed ID: 6433960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multicenter study of a slow-release theophylline: armophylline].
    Akoun G; Battesti JP; Bignon J; Caubarrere I; Charpin J; Chicou JF; Godard P; Herman DM; Julien D; Michel FB
    Poumon Coeur; 1983; 39(6):333-6. PubMed ID: 6364093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG; Moguel A
    Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pharmacokinetics of theopek--a new Soviet prolonged-action drug form of theophylline--in patients with bronchial asthma].
    Belousov IuB; Abazova FI; Kholodov LE; Chervinskaia TA; Sokolov AV
    Farmakol Toksikol; 1989; 52(5):63-8. PubMed ID: 2599082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
    Tinkelman DG; Lutz CN; Miller E; Cole WQ
    Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of two theophylline derivatives in asthmatic patients.
    Jones RW
    J Int Med Res; 1979; 7 Suppl 1():16-21. PubMed ID: 374160
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.